Theravance Bio: Q1 Earnings Snapshot

Published: 2026-05-07 08:40:15 ET TBPH

Published on 05/07/2026 at 08:40 am EDT

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Theravance Biopharma Inc. (TBPH) on Thursday reported a loss of $4.9 million in its first quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 10 cents. Earnings, adjusted for one-time gains and costs, came to 1 cent per share.

The biopharmaceutical company posted revenue of $17.7 million in the period, which did not meet Street forecasts. Four analysts surveyed by Zacks expected $17.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News